Contrast media safety—An update
- 31 October 2011
- journal article
- review article
- Published by Elsevier BV in European Journal of Radiology
- Vol. 80 (1), 77-82
- https://doi.org/10.1016/j.ejrad.2010.12.104
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Iodixanol Versus Low-Osmolar Contrast Media for Prevention of Contrast Induced NephropathyCirculation: Cardiovascular Interventions, 2010
- A European View-Point on NSFCurrent Rheumatology Reviews, 2010
- Intravenous Contrast Medium–induced Nephrotoxicity: Is the Medical Risk Really as Great as We Have Come to Believe?Radiology, 2010
- Nephrogenic systemic fibrosis and contrast medium-induced nephropathy: a choice between the devil and the deep blue sea for patients with reduced renal function?Acta Radiologica, 2009
- Contrast-Induced Nephropathy and Long-Term Adverse EventsClinical Journal of the American Society of Nephrology, 2009
- Nephrotoxicity of Iso-osmolar Iodixanol Compared with Nonionic Low-osmolar Contrast Media: Meta-analysis of Randomized Controlled TrialsRadiology, 2009
- Update on Nephrogenic Systemic FibrosisMagnetic Resonance Imaging Clinics of North America, 2008
- Risk of contrast-medium-induced nephropathy in high-risk patients undergoing MDCT – A pooled analysis of two randomized trialsEuropean Radiology, 2008
- Is NSF only the tip of the “gadolinium toxicity” iceberg?Journal of Magnetic Resonance Imaging, 2008
- Contrast-induced nephropathy: the wheel has turned 360 degreesActa Radiologica, 2008